The NOD2 variants might lose this negative repressive role on the Toll-like receptor, leading to dysregulated activation of the NFκB immune signaling pathway, resulting in a high immune response that may be linked to IBD [178]. Here, NOD2 is linked to inflammatory bowel disease.